NASDAQ: WHWK
Whitehawk Therapeutics Inc
Healthcare · Biotechnology
After hours: $4.68(+0.89%) · as of 7:34 PM ET
Market Cap
$264.52M
52w High
$5.50
52w Low
$1.57
P/E
-4.14
Volume
334.29K
Outstanding Shares
57.01M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 188.2% over the last year. Revenue declined 100% over the trailing twelve months. Free cash flow grew 28.13% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive move in revenue — currently down 100% — would be the clearest signal to resolve the ambiguity.
Company profile
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials.
Valuation
Stock splits
Every 1 shares became 15
Profitability & growth
Analyst consensus
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est -$0.27 · Revenue est —
View